Cambridge Heart Antioxidant Study

Stephens, N.G., Parsons, A., Schodiel, P.M., Kelly, F., Cheeseman, K., and Mitchinson, M.J. 1996. Randomised controlled trial of vitamin E in patients with coronary disease Cambridge heart antioxidant study (CHAOS). Lancet 347, 781-786. [Pg.163]

Cambridge Heart Antioxidant Study DATATOR Deprenyl and Tocopherol Antioxidative Therapy of Rarkinsonism FMC, Finnish Mobile Clinic Health Examination Survey GISSI, Gruppo Italiano Studio Soprawivenza Infarto HOPE, Heart Outcome Prevention Evaluation HPFS, Health Professional Follow-up Study NHS, Nurses Health Study PPR Primary Prevention Project SPACE, Secondary Prevention with Antioxidants of Cardiovascular disease in End-stage renal disease VEAPS, Vitamin E Atherosclerosis Prevention Study VECAT Vitamin E Cataract Age-related maculopathy Trial. [Pg.220]

Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, and Mitchinson MJ (1996) Randomised controlled trial ofvitaminE inpatients with coronary disease Cambridge Heart Antioxidant Study (CHAOS). Lancet 347,781-6. [Pg.453]

Stephens N G et al 1996 Randomised controlled trial of vitamin E in patients with coronary disease Cambridge heart antioxidant study. Lancet 347 781-786. [Pg.527]

Acronyms and abbreviations PHSl, Physician s Health Study I CHAOS, Cambridge Heart Antioxidant Study ATBC, Alpha-Tocopherol, Beta-Carotene Cancer Prevention Stirdy NHS, Nurses Healtli Study CVD, cardiovascular disease ALS, amyotrophic lateral sclerosis NMD A, A-methyl-D-aspartate glutamate receptors. [Pg.111]

ACE, angiotensin converting enzyme ATBC, Alpha Tocopherol Beta Carotene Prevention Study CHAOS, Cambridge Heart Antioxidant Study GiSSi, GiSSI Prevenzione Triai HOPE, Heart Outcomes Prevention Evaluation Study HPS, Heart Protection Study CHD, Coronary Heart Disease CVD, cardiovascuiar disease Ml, myocardial infarction PUPA, polyunsatutated fatty acids. [Pg.34]

The ability of a-tocopherol supplementation to prevent cardiovascular events in different populations was tested in four larger prospective clinical trials The a-Tocopherol, yS-Carotene Cancer Prevention (ATBC) study, the Cambridge Heart Antioxidant Study (CHAOS), the Gruppo Italiano per lo studio della Sopravvivenza nell Infarto Miocar-dito (GISSI) trial, and the Heart Outcome Prevention Evaluation (HOPE) study. In addition, at least two smaller prospective clinical trials have been completed the Secondary Prevention with... [Pg.483]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...